Clinical use of pre-emptive pharmacogenetic programmes

被引：10

作者：

Penas-LLedo, Eva ^{[1
,2
]}

LLerena, Adrian ^{[1
,2
,3
]}

机构：

[1] INUBE Extremadura Biosanit Univ Res Inst, Extremadura, Spain

[2] Univ Extremadura, Med Sch, E-06080 Badajoz, Spain

[3] Inst Salud Carlos III, CIBERSAM, Madrid, Spain

来源：

LANCET | 2023年 / 401卷 / 10374期

关键词：

POLYPHARMACY;

D O I：

10.1016/S0140-6736(22)02461-8

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：320 / 321

页数：2

共 9 条

[1] Comparison of the Guidelines of the Clinical Pharmacogenetics Implementation Consortium and the Dutch Pharmacogenetics Working Group [J].

Bank, P. C. D. ;

Caudle, K. E. ;

Swen, J. J. ;

Gammal, R. S. ;

Whirl-Carrillo, M. ;

Klein, T. E. ;

Relling, M. V. ;

Guchelaar, H-J .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 103 (04) :599-618

[2] The effect of pharmacogenetic profiling with a clinical decision support tool on healthcare resource utilization and estimated costs in the elderly exposed to polypharmacy [J].

Brixner, D. ;

Biltaji, E. ;

Bress, A. ;

Unni, S. ;

Ye, X. ;

Mamiya, T. ;

Ashcraft, K. ;

Biskupiak, J. .

JOURNAL OF MEDICAL ECONOMICS, 2016, 19 (03) :213-228

[3]

Clinical Pharmacogenetics Implementation Consortium, 2021, GUIDELINES

[4] Clinical impact of pharmacogenetic profiling with a clinical decision support tool in polypharmacy home health patients: A prospective pilot randomized controlled trial [J].

Elliott, Lindsay S. ;

Henderson, John C. ;

Neradilek, Moni B. ;

Moyer, Nicolas A. ;

Ashcraft, Kristine C. ;

Thirumaran, Ranjit K. .

PLOS ONE, 2017, 12 (02)

[5] Pharmacogenetic polymorphism as an independent risk factor for frequent hospitalizations in older adults with polypharmacy: a pilot study [J].

Finkelstein, Joseph ;

Friedman, Carol ;

Hripcsak, George ;

Cabrera, Manuel .

PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2016, 9 :107-116

[6] A one-year follow-up study of treatment-compliant suicide attempt survivors: relationship of CYP2D6-CYP2C19 and polypharmacy with suicide reattempts [J].

Penas-Lledo, Eva M. ;

Guillaume, Sebastien ;

de Andres, Fernando ;

Cortes-Martinez, Ana ;

Dubois, Jonathan ;

Kahn, Jean Pierre ;

Leboyer, Marion ;

Olie, Emilie ;

LLerena, Adrian ;

Courtet, Philippe .

TRANSLATIONAL PSYCHIATRY, 2022, 12 (01)

[7] CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials [J].

Penas-LLedo, Eva M. ;

LLerena, Adrian .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 77 (04) :673-683

[8] CYP450 genotype and pharmacogenetic association studies: a critical appraisal [J].

Shah, Rashmi R. ;

Gaedigk, Andrea ;

LLerena, Adrian ;

Eichelbaum, Michel ;

Stingl, Julia ;

Smith, Robert L. .

PHARMACOGENOMICS, 2016, 17 (03) :259-275

[9] A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study [J].

Swen, Jesse J. ;

van der Wouden, Cathelijne H. ;

Manson, Lisanne E. N. ;

Abdullah-Koolmees, Heshu ;

Blagec, Kathrin ;

Blagus, Tanja ;

Boehringer, Stefan ;

Cambon-Thomsen, Anne ;

Cecchin, Erika ;

Cheung, Ka-Chun ;

Deneer, Vera H. M. ;

Dupui, Mathilde ;

Ingelman-Sundberg, Magnus ;

Jonsson, Siv ;

Joefield-Roka, Candace ;

Just, Katja S. ;

Karlsson, Mats O. ;

Konta, Lidija ;

Koopmann, Rudolf ;

Kriek, Marjolein ;

Lehr, Thorsten ;

Mitropoulou, Christina ;

Rial-Sebbag, Emmanuelle ;

Rollinson, Victoria ;

Roncato, Rossana ;

Samwald, Matthias ;

Schaeffeler, Elke ;

Skokou, Maria ;

Schwab, Matthias ;

Steinberger, Daniela ;

Stingl, Julia C. ;

Tremmel, Roman ;

Turner, Richard M. ;

van Rhenen, Mandy H. ;

Fajardo, Cristina L. Davila ;

Dolzan, Vita ;

Patrinos, George P. ;

Pirmohamed, Munir ;

Sunder-Plassmann, Gere ;

Toffoli, Giuseppe ;

Guchelaar, Henk-Jan .

LANCET, 2023, 401 (10374) :347-356

← 1 →